Literature DB >> 20826697

The globoside receptor triggers structural changes in the B19 virus capsid that facilitate virus internalization.

Claudia Bönsch1, Christoph Zuercher, Patricia Lieby, Christoph Kempf, Carlos Ros.   

Abstract

Globoside (Gb4Cer), Ku80 autoantigen, and α5β1 integrin have been identified as cell receptors/coreceptors for human parvovirus B19 (B19V), but their role and mechanism of interaction with the virus are largely unknown. In UT7/Epo cells, expression of Gb4Cer and CD49e (integrin alpha-5) was high, but expression of Ku80 was insignificant. B19V colocalized with Gb4Cer and, to a lesser extent, with CD49e. However, only anti-Gb4Cer antibodies could disturb virus attachment. Only a small proportion of cell-bound viruses were internalized, while the majority became detached from the receptor. When added to uninfected cells, the receptor-detached virus showed superior cell binding capacity and infectivity. Attachment of B19V to cells triggered conformational changes in the capsid leading to the accessibility of the N terminus of VP1 (VP1u) to antibodies, which was maintained in the receptor-detached virus. VP1u became similarly accessible to antibodies following incubation of B19V particles with increasing concentrations of purified Gb4Cer. The receptor-mediated exposure of VP1u is critical for virus internalization, since capsids lacking VP1 could bind to cells but were not internalized. Moreover, an antibody against the N terminus of VP1u disturbed virus internalization, but only when present during and not after virus attachment, indicating the involvement of this region in binding events required for internalization. These results suggest that Gb4Cer is not only the primary receptor for B19V attachment but also the mediator of capsid rearrangements required for subsequent interactions leading to virus internalization. The capacity of the virus to detach and reattach again would enhance the probability of productive infections.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20826697      PMCID: PMC2977879          DOI: 10.1128/JVI.01143-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Identification of an immunodominant peptide in the parvovirus B19 VP1 unique region able to elicit a long-lasting immune response in humans.

Authors:  E Zuffi; E Manaresi; G Gallinella; G A Gentilomi; S Venturoli; M Zerbini; M Musiani
Journal:  Viral Immunol       Date:  2001       Impact factor: 2.257

2.  Depletion of virion-associated divalent cations induces parvovirus minute virus of mice to eject its genome in a 3'-to-5' direction from an otherwise intact viral particle.

Authors:  Susan F Cotmore; Susan Hafenstein; Peter Tattersall
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

3.  The VP1 N-terminal sequence of canine parvovirus affects nuclear transport of capsids and efficient cell infection.

Authors:  Maija Vihinen-Ranta; Dai Wang; Wendy S Weichert; Colin R Parrish
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

4.  Cytoplasmic trafficking of minute virus of mice: low-pH requirement, routing to late endosomes, and proteasome interaction.

Authors:  Carlos Ros; Christoph J Burckhardt; Christoph Kempf
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  Trafficking and propagation of canine adenovirus vectors lacking a known integrin-interacting motif.

Authors:  M Chillon; E J Kremer
Journal:  Hum Gene Ther       Date:  2001-09-20       Impact factor: 5.695

6.  The VP1-unique region of parvovirus B19: amino acid variability and antigenic stability.

Authors:  Simone Dorsch; Bärbel Kaufmann; Uwe Schaible; Elke Prohaska; Hans Wolf; Susanne Modrow
Journal:  J Gen Virol       Date:  2001-01       Impact factor: 3.891

7.  The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity.

Authors:  Anne Girod; Christiane E Wobus; Zoltán Zádori; Martin Ried; Kristin Leike; Peter Tijssen; Jürgen A Kleinschmidt; Michael Hallek
Journal:  J Gen Virol       Date:  2002-05       Impact factor: 3.891

8.  A viral phospholipase A2 is required for parvovirus infectivity.

Authors:  Z Zádori; J Szelei; M C Lacoste; Y Li; S Gariépy; P Raymond; M Allaire; I R Nabi; P Tijssen
Journal:  Dev Cell       Date:  2001-08       Impact factor: 12.270

9.  Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells.

Authors:  K A Weigel-Kelley; M C Yoder; A Srivastava
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

10.  Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry.

Authors:  Kirsten A Weigel-Kelley; Mervin C Yoder; Arun Srivastava
Journal:  Blood       Date:  2003-08-07       Impact factor: 22.113

View more
  23 in total

1.  Globoside Is Dispensable for Parvovirus B19 Entry but Essential at a Postentry Step for Productive Infection.

Authors:  Jan Bieri; Carlos Ros
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

2.  In vitro encapsulation of heterologous dsDNA into human parvovirus B19 virus-like particles.

Authors:  Sandra Paola Sánchez-Rodríguez; Joana Valeria Enrriquez-Avila; Juan Miguel Soto-Fajardo; Carolina Peña-Montes; Ismael Bustos-Jaimes
Journal:  Mol Biotechnol       Date:  2015-04       Impact factor: 2.695

3.  Characterization of the early steps of human parvovirus B19 infection.

Authors:  Silva Quattrocchi; Nico Ruprecht; Claudia Bönsch; Sven Bieli; Christoph Zürcher; Klaus Boller; Christoph Kempf; Carlos Ros
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

4.  Structure of Parvovirus B19 Decorated by Fabs from a Human Antibody.

Authors:  Yingyuan Sun; Thomas Klose; Yue Liu; Susanne Modrow; Michael G Rossmann
Journal:  J Virol       Date:  2019-04-17       Impact factor: 5.103

Review 5.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 6.  Blood Groups in Infection and Host Susceptibility.

Authors:  Laura Cooling
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

7.  Parvovirus B19 uptake is a highly selective process controlled by VP1u, a novel determinant of viral tropism.

Authors:  Remo Leisi; Nico Ruprecht; Christoph Kempf; Carlos Ros
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

8.  Complex and Dynamic Interactions between Parvovirus Capsids, Transferrin Receptors, and Antibodies Control Cell Infection and Host Range.

Authors:  Heather M Callaway; Kathrin Welsch; Wendy Weichert; Andrew B Allison; Susan L Hafenstein; Kai Huang; Sho Iketani; Colin R Parrish
Journal:  J Virol       Date:  2018-06-13       Impact factor: 5.103

9.  The N-terminal 5-68 amino acids domain of the minor capsid protein VP1 of human parvovirus B19 enters human erythroid progenitors and inhibits B19 infection.

Authors:  Wei Zou; Kang Ning; Peng Xu; Xuefeng Deng; Fang Cheng; Steve Kleiboeker; Jianming Qiu
Journal:  J Virol       Date:  2021-05-05       Impact factor: 5.103

Review 10.  Ceramide and Related Molecules in Viral Infections.

Authors:  Nadine Beckmann; Katrin Anne Becker
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.